Dr. David Allen Weatherford, MD

Dr. Weatherford practices at Coastal Vascular Institute, PA in Wilmington, North Carolina.

Dr. Weatherford's NPI, 1326131525, was assigned on October 2, 2006. Dr. Weatherford graduated from Medical University of South Carolina College of Medicine in 1989. Dr. Weatherford holds North Carolina license 97-00417.

Dr. Weatherford's primary practice is Coastal Vascular Institute, PA, at 1411 Physicians Dr, Wilmington, NC 28401 in New Hanover County. The practice phone is (910) 343-0811.

Dr. Weatherford's primary practice is Coastal Vascular Institute, PA in Wilmington, North Carolina. Dr. Weatherford is also affiliated with Novant Health New Hanover Regional Medical Center. The medical group on file is Novant Health Heart & Vascular Institute, Wilmington Main. Dmand AI also links Dr. Weatherford to 3 more hospitals, 2 group practices and clinics, 2 home health agencies and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Weatherford practices, 8 sites in all. Vendor and product names are available with a free account.

Surgery is Dr. Weatherford's primary specialty in the NPI Registry, under taxonomy code 208600000X. Dr. Weatherford is licensed in North Carolina.

CMS data shows 2,804 Medicare services from Dr. Weatherford across 24 procedure codes in 2024, for 963 Medicare patients. Medicare paid $386,231 for them.

CMS counts 963 Medicare patients who saw Dr. Weatherford in 2024. The largest group is 75 to 84, with 434 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 10% are also on Medicaid. Their average risk score is 2.07, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Weatherford's median patient age at 73, with 47% women.

In 2024, Dr. Weatherford wrote 317 Medicare Part D claims for 117 patients. 90% of them were for generic drugs. CMS names the drug for 257 of them, across 5 drugs with 11 or more claims each, at $14,893 in total drug cost. In 2023, CMS named 341 claims across 7 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Weatherford for performance year 2024, reported as part of a group. Dr. Weatherford accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 36 procedures of leg revascularization (restoring blood flow) by Dr. Weatherford, more than 91% of the clinicians it reports for that procedure.

Dmand AI links 1 paper to Dr. Weatherford. Dr. Weatherford's most frequent co-authors are Thomas V. Clancy, MD, Devan Griner, MD and James D. Hundley, MD.

Dmand AI links Dr. Weatherford to 8 clinical trials. 3 are still active or recruiting. Conditions studied include Peripheral Arterial Disease, Atherosclerosis and Chronic Limb-Threatening Ischemia. Boston Scientific Corporation sponsors the most, 3. Open Payments lists research payments to Dr. Weatherford that name 3 trials.

CMS Open Payments shows 313 general payments to Dr. Weatherford from 54 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 79% of the total. Medtronic Vascular, Inc. paid the most, $2,420. It also lists 32 research payments totaling $39,326 from 2016 to 2023, naming 3 clinical trials.

Dr. Weatherford graduated from Medical University of South Carolina College of Medicine in 1989.